Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
2.720
+1.315 (93.59%)
At close: Jan 30, 2026, 4:00 PM EST
2.750
+0.030 (1.10%)
After-hours: Jan 30, 2026, 7:38 PM EST

Tempest Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1336851236-
Market Cap Growth
-65.61%-57.00%600.22%-66.85%--
Enterprise Value
143295-14-4-
Last Close Price
2.7210.8557.2014.9568.64-
PB Ratio
1.901.903.160.671.01-
P/TBV Ratio
2.111.903.160.671.01-
Debt / Equity Ratio
1.320.800.771.220.510.14
Quick Ratio
2.132.134.174.292.595.84
Current Ratio
2.302.214.294.533.446.15
Return on Equity (ROE)
-405.03%-182.35%-131.42%-131.70%-104.76%-196.78%
Return on Assets (ROA)
-89.32%-56.43%-37.31%-36.29%-35.10%-79.27%
Return on Capital Employed (ROCE)
-267.70%-154.10%-69.10%-89.30%-50.70%-98.30%
Earnings Yield
-269.02%-114.89%-34.82%-295.25%-77.57%-
FCF Yield
-249.20%-91.88%-32.50%-261.55%-71.51%-
Buyback Yield / Dilution
-114.19%-80.99%-33.49%-204.70%-709.63%44.17%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q